Besides, our data also showed that CYP2S1 knockdown selectively decreased migration and invasion ability of BRAFV600E-mutated thyroid cancer cells compared to the control (Fig. 2e). This evidence concerns the gene CYP2S1 and thyroid gland carcinoma.